World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00263159
Date of registration: 06/12/2005
Primary sponsor: University Ghent
Public title: Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study
Scientific title: Pharmaceutical Care for Asthma Control Improvement
Date of first enrolment: January 2006
Target sample size: 221
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00263159
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label  
Countries of recruitment
Belgium
Contacts
Name:   Guy Brusselle, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital, Ghent
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with persistent asthma

- Asthma treatment for at least 12 months

- Regular visitors of the participating community pharmacy

Exclusion Criteria:

- Severe co-morbidity

- > 10 pack-years smoking history

- Asthma Control Test score < 15 or =25



Age minimum: 18 Years
Age maximum: 50 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Asthma
Intervention(s)
Procedure: Pharmaceutical care for asthma patients
Primary Outcome(s)
The difference between study groups in the change of asthma control from baseline and follow-up visits [Time Frame: after 1, 3 and 6 months]
Secondary Outcome(s)
Asthma exacerbations [Time Frame: after 6 months]
Asthma quality of life questionnaire (AQLQ) [Time Frame: after 6 months]
General Practitioner (GP) visits, emergency room visits and hospitalisations
Inhalation techniques [Time Frame: after 6 months]
Knowledge of asthma and treatment [Time Frame: after 6 months]
Peak flow [Time Frame: after 3 and 6 months]
Smoking [Time Frame: after 6 months]
Therapy adherence
Working days lost and school days lost
Secondary ID(s)
2005/320
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history